Unknown

Dataset Information

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review.


ABSTRACT: Ovarian cancer is the most common cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease; although chemotherapeutic advances have improved progression-free survival, conventional treatments offer limited results in terms of long-term responses and survival. Research has recently focused on targeted therapies, which represent a new, promising therapeutic approach, aimed to maximize tumor kill and minimize toxicity. Besides antiangiogenetic agents and poly (ADP-ribose) polymerase inhibitors, the folate, with its membrane-bound receptor, is currently one of the most investigated alternatives. In particular, folate receptor (FR) has been shown to be frequently overexpressed on the surface of almost all epithelial ovarian cancers, making thi

SUBMITTER: Marchetti C 

PROVIDER: S-EPMC4096491 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature